Benjamin G. Neel, MD, PhD
Professor of Medicine, NYU School of Medicine
Director, Laura and Isaac Perlmutter Cancer Center
contact : firstname.lastname@example.org
Toshiyuki Araki, PhD
Research Assistant Professor
Ph.D., 2000, Protein Research Institute, Suita Japan
My work focuses on the Role of RAS/ERK signaling in human development and cancers.
contact : email@example.com
Post Doctoral Fellows
Ph.D., 2016, National Institute of Immunology, JNU, New Delhi/ India
Investigating the role of PTP1B in regulating RNF213, the identification and function of RNF213 substrates and the detailed mechanism of RNF213 ubiquitin ligase activity.
contact : firstname.lastname@example.org
Ph.D., 2017, University of Birmingham, UK
I am studying kinase-phosphatase mediated signaling in leukemia development, particularly the role of specific ERK isoforms in normal hematopoiesis and myeloproliferative disorders.
contact : email@example.com
Ph.D., 2015, National Cheng Kung University, Tainan, Taiwan
I am studying autophagy-mediated tumor progression and tumor microenvironment modulation.
contact : firstname.lastname@example.org
Kwan Ho Tang
Ph.D., 2013, Chinese Academy of Science, Beijing, China
Ph.D., University of Hong Kong
I am studying the effects of SHP2 inhibitors on the tumor microenvironment in lung and pancreas cancer, and also using scRNAseq to define cellular hieracrchies in normal fallopian tube and ovarian cancer.
contact : email@example.com
MS of Biology from NYU, 2014
I studying mechanisms of cancer cell resistance to SHP2 inhibitors.
contact : firstname.lastname@example.org
BA in Biological Sciences from Cornell University, 2015
I study the role of PZR in the immune system as well as the role of shp2 binding proteins in downregulating the immune response in cancer.
Kiyomi Araki, Ph.D.
contact : email@example.com